Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Characteristics of heart involvement in MS patients treated with MTX

From: Cardiovascular comorbidity in multiple sclerosis patients treated with Mitoxantrone therapy: a cohort study

Type of heart involvement Percent Number
Heart dysfunction (any type) 12.5 33
Symptomatic heart failure 2.7 7
ECG abnormalities/arrhythmias 3.1 8
Myocardial infarction 0.4 1
Death due to heart failure 0.4 1
Deaths due to other causes (heat shock) 0.4 1